Skip to main content
. Author manuscript; available in PMC: 2020 Mar 26.
Published in final edited form as: Can J Anaesth. 2016 Jul 28;63(11):1223–1232. doi: 10.1007/s12630-016-0704-0

Table 1.

Patient demographics and intraoperative characteristics

Variable Lidocaine (n = 105) Placebo (n = 97)
Age, yr 69 (10) 67 (10)
Sex, % female 34 23
Race, % white 94 91
Weight, kg 80 (17) 83 (18)
History of hypertension, % 61 53
Previous myocardial infarction, % 14 23
LV ejection fraction, % 52 (9) 52 (12)
Preoperative statin use, % 30 32
Preoperative antiplatelet use, % 27 36
Surgical procedure, %
 CABG 24 37
 CABG + Valve 13 18
 Valve only 61 45
 Other* 2 0
Number of grafts** 1 (1) 2 (2)
Cross-clamp time, min 94 (35) 90 (42)
CPB time, min 158 (43) 164 (60)

Data are represented as mean (standard deviation), except where indicated; CABG = coronary artery bypass grafting; CPB = cardiopulmonary bypass; LV = left ventricular.

*

Two patients in the lidocaine group had additional procedures at the time of surgery.

**

Number of grafts is reported only for patients who underwent CABG or CABG + Valve